BEIJING and GUANGZHOU, China, March 2, 2026 /PRNewswire/ — SALIAI (“Guangzhou SALIAI Stem Cell Science and Technology Co., Ltd.” and “Guangzhou SALIAI Biological Gene Engineering Co., Ltd.,” collectively known as “SALIAI”) is a China-based biotechnology firm engaged in stem cell analysis and associated business purposes. The Company states that it was the primary stem cell-focused firm quoted on the National Equities Exchange and Quotations (NEEQ), China’s New Third Board market.
Statement of Market Position
SALIAI develops and commercializes mobile extract–primarily based merchandise and associated applied sciences. Its actions embrace analysis and improvement in cell-based cosmeceuticals and investigational packages in regenerative drugs.
In February 2026, Shangpu Group, a China-based analysis and advisory agency, issued SALIAI a “Global Pioneer in Patented Cellular Essence” market place assertion following what it described as a world market research. According to Shangpu Group, the designation displays its evaluation of SALIAI’s technological place inside an outlined market section and doesn’t represent a regulatory classification, certification, or authorities endorsement.
SALIAI holds High-Tech Enterprise standing in China and has been designated as a National Enterprise Technology Center in stem cell. It has additionally acquired nationwide mental property recognition. Founded in 2009 and headquartered at Guangzhou International Bio Island, the corporate conducts mobile analysis and develops associated business purposes. Its operations embrace laboratory analysis, course of improvement, and manufacturing of patented mobile extracts.
The Company reviews holding greater than 300 approved patents, together with 5 recipients of the National Patent Excellence Award. Its patent portfolio consists of applied sciences associated to umbilical wire–derived extracts and exosome-associated processes, with sure patents granted in each China and the United States. The Company participates in additional than 30 analysis initiatives on the nationwide, provincial, and municipal ranges.
SALIAI has been engaged in stem cell analysis for roughly 16 years. Led by Founder Dr. Chen Haijia, the Company maintains a scientific and technical group targeted on mobile analysis and associated purposes. Academician Su Guohui serves as Chief Scientist. The Company operates analysis services, together with government-designated Academician Workstations, and maintains a GMP-compliant manufacturing facility with ISO and CNAS certifications.
Its proprietary freeze-drying course of, performed at minus 40 levels Celsius, is designed to protect mobile materials beneath managed circumstances. In mixture with nano-scale supply methods, the know-how is meant to help formulation stability and topical supply in beauty purposes.
Commercial merchandise embrace SYDRAW Intelligent Polypeptide Lyophilized Powder and Bio Island Anti-Wrinkle and Firming Essence Set, that are marketed inside China’s cosmetics sector. The merchandise have undergone third-party testing and have acquired the designation “Guangdong Premium Cosmetics,” a provincial high quality recognition.
SALIAI focuses on science-based product improvement in skincare and mobile applied sciences. The Company participated within the improvement of three nationwide affiliation requirements associated to mobile extracts, contributing to technical pointers inside its business.
The Company additionally serves in management roles inside business associations and has organized the International Stem Cell and Precision Medicine Industrialization Conference yearly for the previous ten years.
Through analysis collaborations with medical establishments—together with research associated to stem cell approaches for knee osteoarthritis—the Company conducts medical analysis packages at numerous phases of improvement.
The Company additionally helps company social accountability initiatives, together with funding the development of Hope Primary Schools in China and establishing science and know-how innovation funds. Its company mission is: “Science and love will guard life.”
SALIAI intends to proceed investing in analysis and improvement associated to its patented mobile applied sciences. The Company is conducting medical analysis packages involving stem cell–primarily based therapeutic candidates, together with investigational approaches associated to knee osteoarthritis, topic to relevant regulatory and medical trial necessities.
The Company is implementing digital methods to help manufacturing oversight, high quality administration, and operational processes because it expands internationally.
SALIAI is establishing a Stem Cell Innovation Association within the Guangdong-Hong Kong-Macao Greater Bay Area to help analysis translation and business collaboration throughout cosmeceuticals and regenerative drugs.
The Company goals to increase the worldwide software of its mobile analysis and product improvement capabilities. Its company imaginative and prescient is: “Make health and beauty within reach.”